The IPO market in 2025 is being driven by a clear theme — bigger is better

The 2025 IPO market is demonstrating robust performance, particularly for large-cap companies across diverse sectors, including AI, crypto, medtech, and ESG. Notably, marquee debutants like Circle and CoreWeave have seen shares surge over 300-500%, contributing to a 20% Q2 gain for the Renaissance IPO ETF and erasing prior losses. This strong aftermarket reception for a broader group of IPOs, despite a temporary slowdown in June/July due to tariff uncertainty, is encouraging more large private firms, such as Figma, to pursue public listings, signaling an anticipated rebound in IPO volume this fall.

Analysis

The 2025 IPO market is exhibiting significant strength, characterized by a clear investor preference for large-capitalization companies across diverse, high-growth sectors. The volume of US IPOs for companies over $50 million in market cap has increased 42.9% year-over-year. Marquee listings in AI and crypto, such as CoreWeave (CRWV) and Circle (CRCL), have seen their shares surge over 310% and 500% respectively, achieving market caps exceeding $45 billion. This robust performance is not confined to technology; medtech firm Anbio Biotechnology (NNNN) is up over 630% and ESG solutions provider Diginex Limited (DGNX) has gained 930%. This broad-based success is reflected in the Renaissance IPO ETF (IPO), which posted a 20% gain in Q2, erasing a 14% Q1 loss. The strong aftermarket performance is creating a positive feedback loop, encouraging other large private companies like Figma, last valued at $12.5 billion, to pursue public offerings. While IPO activity in June and July was reportedly subdued due to uncertainty around trade tariffs, market experts anticipate a strong rebound in issuance volume this fall, fueled by sustained investor appetite for well-received, large-scale debuts.

Key Decisions for Investors

• Investors should prioritize due diligence on upcoming large-cap IPOs, as the market is clearly rewarding scale and strong narratives in sectors like AI, crypto, medtech, and ESG.
• Monitor for a potential acceleration in IPO filings this fall, as the recent success of major listings is prompting other large private firms to enter the public markets.
• Consider thematic instruments like the Renaissance IPO ETF (IPO) for diversified exposure to the market's recovery, given its strong Q2 performance and the broad-based success of its underlying components.
• Remain aware of macroeconomic risks, such as trade policy uncertainty, which temporarily dampened issuance volume and could influence the timing and reception of future offerings.